Toggle light / dark theme

Tesla CEO Elon Musk has alluded to an upcoming “tap to park” feature for the automaker’s Full Self-Driving (FSD) beta. While it isn’t clear when it’s expected to become available, some have already pointed out how useful such a feature could be.

On Friday, Musk responded to a post on X saying that Tesla is developing a feature in which the car identifies potential parking space options, letting users tap the one they want to use. Upon doing so, the driver will then be able to leave the vehicle before the vehicle parks in the selected space.

The statement came in response to another post claiming that a 360-degree bird’s eye view would be irrelevant in a world of self-driving vehicles, as the driver wouldn’t need to do anything at all for the vehicle to locate and park in a specific spot.


Abstract. Individual differences in the spatial organization of resting-state networks have received increased attention in recent years. Measures of individual-specific spatial organization of brain networks and overlapping network organization have been linked to important behavioral and clinical traits and are therefore potential biomarker targets for personalized psychiatry approaches. To better understand individual-specific spatial brain organization, this paper addressed three key goals. First, we determined whether it is possible to reliably estimate weighted (non-binarized) resting-state network maps using data from only a single individual, while also maintaining maximum spatial correspondence across individuals. Second, we determined the degree of spatial overlap between distinct networks, using test-retest and twin data.

A team of researchers based at the University of Toronto’s (U of T) Leslie Dan Faculty of Pharmacy has discovered a novel ionizable lipid nanoparticle that enables muscle-focused mRNA delivery while minimizing off-target delivery to other tissues. The team also showed that mRNA delivered by the lipid nanoparticles investigated in their study triggered potent cellular-level immune responses as a proof-of-concept melanoma cancer vaccine.

The study, led by Bowen Li, assistant professor, Leslie Dan Faculty of Pharmacy, U of T, was published this week in Proceedings of the National Academy of Sciences.

Called iso-A11B5C1, the new nanoparticle demonstrates exceptional mRNA delivery efficiency in muscle tissues while also minimizing unintended mRNA translation in organs such as the liver and spleen.